Live·Open questions in longevity research
All news
Longevity research

In cultured human cells, a protein tag on lysosomal membranes promotes lysosome expansion that helps damaged cells survive by becoming senescent; cells lacking the tag die more often than control cells, Toren Finkel's laboratory finds

13 November 2026· 261113004

In cultured human cells, a protein tag on lysosomal membranes promotes lysosome expansion that helps damaged cells survive by becoming senescent; cells lacking the tag die more often than control cells, Toren Finkel's laboratory finds

On November 9, JCI Insight published a paper from the laboratory of Toren Finkel, director of the University of Pittsburgh's Aging Institute. The researchers disabled CASM, the pathway that adds this tag, in human airway epithelial cells and skin fibroblasts.

A damaged cell can die or become senescent: it stops dividing but remains alive, and its lysosomes increase in number.

A 2023 study by Bernadette Carroll's group at the University of Bristol showed why senescent cells need so many lysosomes. Individual lysosomes function less effectively in these cells, but their greater number keeps the cells' overall capacity to break down material at the level found in dividing cells. The proteins TFEB and TFE3 direct lysosome production, and senescent cells die without them.

TFEB is usually activated during starvation: the nutrient sensor mTORC1 stops retaining it in the cytoplasm, allowing TFEB to enter the nucleus and activate lysosomal genes. In senescent cells, mTORC1 remains active, yet TFEB still enters the nucleus. What activates TFEB under these conditions had remained unclear.

Studies of lysosomal stress offered a clue. Cells tag membranes with ATG8 proteins. During conventional autophagy, these tags are attached to the double membrane of a vesicle that encloses cellular waste. The same proteins can also tag a single membrane, such as the membrane of a damaged lysosome, through a process called CASM. In a 2021 study, this tag activated TFEB by sequestering a protein complex that helps mTORC1 retain TFEB in the cytoplasm, while mTORC1 continued to act on its other targets as before.

Finkel's laboratory tested whether CASM activates TFEB in senescent cells. The researchers induced senescence using the DNA-damaging agents doxorubicin and bleomycin, as well as hydrogen peroxide. TFEB entered the nucleus in all three cases. After doxorubicin treatment, mTORC1 activity toward its best-known target remained largely unchanged, while ATG8 tagging of lysosomes increased. Disabling any of the three proteins that attach the tag (ATG16L1, ATG12, ATG5) reduced TFEB entry into the nucleus. Cells lacking ATG16L1 also showed less lysosome expansion, with a smaller increase in lysosomal proteins.

These proteins are also required for conventional autophagy, so the authors used three approaches to distinguish its effects from those of CASM. Both a mutant ATG16L1 that selectively disrupts CASM and the Salmonella protein SopF, which blocks CASM, impaired TFEB entry into the nucleus. By contrast, deleting ATG13, a gene required only for conventional autophagy, left TFEB entry into the nucleus unchanged.

Because senescent cells die without TFEB and TFE3, and CASM activates TFEB, cells lacking CASM would be expected to die more often and become senescent less often. Three days after doxorubicin treatment, more of these cells had died. Skin fibroblasts treated with bleomycin showed the same pattern. Without stress, cells lacking CASM grew normally, and staurosporine, which triggers programmed cell death, killed them at the same rate as control cells. Their increased vulnerability appeared only under stress that induces senescence.

The researchers introduced a TFEB variant that stays in the nucleus without a CASM signal into cells lacking ATG16L1. This restored the increase in lysosomal proteins, reduced cell death to the control level, and restored the number of senescent cells on the sixth day. The authors suggest that dividing cells have lysosomal capacity to spare, whereas senescent cells accumulate damaged proteins and die unless their lysosomes expand.

The authors write:

“The CASM–TFEB axis represents a potentially promising therapeutic target for selectively eliminating harmful senescent cells.”

Originally published on Telegram by Ukhvat NewsView on Telegram
Sources
#cellular-senescence#lysosomes#casm#tfeb#atg8#mtorc1